Historical record - last NADAC publication: 10/19/2022
Product Information
EZETIMIBE-SIMVASTATIN 10-20 MG is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $0.4808 per EA under NDC 69238115609. Its NADAC has been published 252 times since Dec 27, 2017.
Strength
10; 20 mg/1; mg/1
Manufacturer
Amneal Pharmaceuticals NY LLCNDC
69238115609
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
10/19/2022
Active Ingredients
EZETIMIBE; SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA208831On Market Since
11/21/2017
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE-SIMVASTATIN 10-20 MG has been published 252 times since Dec 27, 2017, and over the history we have for it it has declined 83.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4808 per EA |
|---|---|
| All-time high | $2.8281 (Jan 10, 2018) |
| All-time low | $0.3680 (Sep 21, 2022) |
| Median price | $1.6561 |
| Average price | $1.5045 |
| Largest weekly change | -39.2% (Oct 21, 2020) |
| Weeks tracked | 252 |
| Tracking since | Dec 27, 2017 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EZETIMIBE-SIMVASTATIN 10-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE-SIMVASTATIN 10-20 MG, manufactured by Amneal Pharmaceuticals NY LLC, is $0.4808 per EA (NDC 69238115609), effective Oct 19, 2022.
How has the price of EZETIMIBE-SIMVASTATIN 10-20 MG changed over time?
Over the history we have for it, the NADAC for EZETIMIBE-SIMVASTATIN 10-20 MG has declined 83.0%. It has been tracked across 252 weekly CMS publications since Dec 27, 2017.
What are the highest and lowest recorded NADAC prices for EZETIMIBE-SIMVASTATIN 10-20 MG?
Since Dec 27, 2017, the NADAC for EZETIMIBE-SIMVASTATIN 10-20 MG has ranged from a low of $0.3680 (Sep 21, 2022) to a high of $2.8281 (Jan 10, 2018), with a median of $1.6561 per EA.
Are there cheaper alternatives to EZETIMIBE-SIMVASTATIN 10-20 MG?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, EZETIMIBE-SIMVASTATIN 10-20 MG, is $0.3013 per EA — about 37% below EZETIMIBE-SIMVASTATIN 10-20 MG.
Who manufactures EZETIMIBE-SIMVASTATIN 10-20 MG?
EZETIMIBE-SIMVASTATIN 10-20 MG (NDC 69238115609) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification